{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:55:36Z","timestamp":1791284136853,"version":"4.1.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/jcp.0b013e31826686bc","type":"journal-article","created":{"date-parts":[[2012,8,25]],"date-time":"2012-08-25T06:44:07Z","timestamp":1345877047000},"page":"615-621","source":"Crossref","is-referenced-by-count":48,"title":["Neonatal Outcomes After Late-Gestation Exposure to Selective Serotonin Reuptake Inhibitors"],"prefix":"10.1097","volume":"32","author":[{"given":"Luke E.","family":"Grzeskowiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew L.","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janna L.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210128","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/01.jcp.0000150228.61501.e4","article-title":"The use of selective serotonin reuptake inhibitors during pregnancy and breast-feeding: a review and clinical aspects.","volume":"25","author":"Hallberg","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"R2-6-20210128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.reprotox.2010.04.015","article-title":"Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs).","volume":"30","author":"Ellfolk","year":"2010","journal-title":"Reprod Toxicol"},{"key":"R3-6-20210128","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1093\/humrep\/17.10.2580","article-title":". Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters.","volume":"17","author":"Sugiura-Ogasawara","year":"2002","journal-title":"Hum Reprod"},{"key":"R4-6-20210128","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1503\/cmaj.091208","article-title":"Use of antidepressants during pregnancy and the risk of spontaneous abortion.","volume":"182","author":"Nakhai-Pour","year":"2010","journal-title":"CMAJ"},{"key":"R5-6-20210128","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/aje\/155.4.293","article-title":". Role of anxiety and depression in the onset of spontaneous preterm labor.","volume":"155","author":"Dayan","year":"2002","journal-title":"Am J Epidemiol"},{"key":"R6-6-20210128","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/01.psy.0000244025.20549.bd","article-title":". Prenatal depression, prenatal anxiety, and spontaneous preterm birth: a prospective cohort study among women with early and regular care.","volume":"68","author":"Dayan","year":"2006","journal-title":"Psychosom Med"},{"key":"R7-6-20210128","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/aje\/kwf131","article-title":"Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland.","volume":"156","author":"Orr","year":"2002","journal-title":"Am J Epidemiol"},{"key":"R8-6-20210128","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0895-4356(92)90149-H","article-title":". Self-reported depression and negative pregnancy outcomes.","volume":"45","author":"Steer","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"R9-6-20210128","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/archpsyc.63.8.898","article-title":". Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data.","volume":"63","author":"Oberlander","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R10-6-20210128","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0022-3999(95)00018-6","article-title":". Psychosocial factors and pregnancy outcome: A review with emphasis on methodological issues.","volume":"39","author":"Paarlberg","year":"1995","journal-title":"J Psychosom Res"},{"key":"R11-6-20210128","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0165-0327(99)00185-8","article-title":". Obstetric complications in patients with depressiona population-based case-control study.","volume":"61","author":"Preti","year":"2000","journal-title":"J Affect Disord"},{"key":"R12-6-20210128","first-page":"789","article-title":"Maternal psychological stressdepression and low birth weight: is there a relationship Arch Pediatr Adolesc Med.","volume":"144","author":"McAnarney","year":"1990","journal-title":""},{"key":"R13-6-20210128","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.infbeh.2003.09.010","article-title":". Prenatal depression effects on the fetus and the newborn.","volume":"27","author":"Field","year":"2004","journal-title":"Infant Behav Dev"},{"key":"R14-6-20210128","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1037\/0278-6133.19.6.535","article-title":"Depressive symptomatology during pregnancy: evidence for an association with decreased fetal growth in pregnancies of lower social class women.","volume":"19","author":"Hoffman","year":"2000","journal-title":"Health Psychol"},{"key":"R15-6-20210128","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/00006842-200109000-00017","article-title":". Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes.","volume":"63","author":"Chung","year":"2001","journal-title":"Psychosom Med"},{"key":"R16-6-20210128","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1001\/archpediatrics.2009.164","article-title":"Selective serotonin reuptake inhibitor exposure in utero and pregnancy outcomes.","volume":"163","author":"Lund","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R17-6-20210128","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1192\/bjp.bp.107.037101","article-title":". Effects of timing and duration of gestational exposure to serotonin reuptake inhibitor antidepressants: population-based study.","volume":"192","author":"Oberlander","year":"2008","journal-title":"Br J Psychiatry"},{"key":"R18-6-20210128","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1176\/appi.ajp.2008.08081170","article-title":". Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes.","volume":"166","author":"Wisner","year":"2009","journal-title":"Am J Psychiatry"},{"key":"R19-6-20210128","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00737-004-0057-5","article-title":". The impact of depression and fluoxetine treatment on obstetrical outcome.","volume":"7","author":"Suri","year":"2004","journal-title":"Arch Womens Ment Health"},{"key":"R20-6-20210128","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(02)11476-0","article-title":"Preterm delivery.","volume":"360","author":"Slattery","year":"2002","journal-title":"Lancet"},{"key":"R21-6-20210128","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/pds.1462","article-title":". Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy.","volume":"16","author":"Davis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R22-6-20210128","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1001\/archpedi.156.11.1129","article-title":". Perinatal outcome following third trimester exposure to paroxetine.","volume":"156","author":"Costei","year":"2002","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R23-6-20210128","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJM199610033351402","article-title":". Birth outcomes in pregnant women taking fluoxetine.","volume":"335","author":"Chambers","year":"1996","journal-title":"N Engl J Med"},{"key":"R24-6-20210128","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.ajog.2006.02.019","article-title":". Selective serotonin reuptake inhibitors and adverse pregnancy outcomes.","volume":"194","author":"Wen","year":"2006","journal-title":"Am J Ostet Gynecol"},{"key":"R25-6-20210128","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archpedi.158.4.312","article-title":"Neonate characteristics after maternal use of antidepressants in late pregnancy.","volume":"158","author":"Kallen","year":"2004","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R26-6-20210128","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1176\/appi.ajp.159.12.2055","article-title":"Outcomes of prenatal antidepressant exposure.","volume":"159","author":"Simon","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R27-6-20210128","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1471-0528.2007.01518.x","article-title":". Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study.","volume":"115","author":"Maschi","year":"2008","journal-title":"BJOG"},{"key":"R28-6-20210128","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1017\/S0033291709992194","article-title":"Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data.","volume":"40","author":"Reis","year":"2010","journal-title":"Psychol Med"},{"key":"R29-6-20210128","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2125.2008.03261.x","article-title":". Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study.","volume":"66","author":"Diav-Citrin","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R30-6-20210128","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1067\/mpd.2003.139","article-title":". Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy.","volume":"142","author":"Casper","year":"2003","journal-title":"J Pediatr"},{"key":"R31-6-20210128","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1001\/jama.1993.03500170076037","article-title":". Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac).","volume":"269","author":"Pastuszak","year":"1993","journal-title":"JAMA"},{"key":"R32-6-20210128","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1542\/peds.2006-2133","article-title":". Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates.","volume":"119","author":"Ferreira","year":"2007","journal-title":"Pediatrics"},{"key":"R33-6-20210128","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/JCP.0b013e3181bf344c","article-title":". Antidepressant use during pregnancy and the risk of preterm delivery and fetal growth restriction.","volume":"29","author":"Toh","year":"2009","journal-title":"J Clin Psychopharmacol"},{"key":"R34-6-20210128","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.ajog.2005.05.012","article-title":". Citalopram use in pregnancy: prospective comparative evaluation of pregnancy and fetal outcome.","volume":"193","author":"Sivojelezova","year":"2005","journal-title":"Am J Ostet Gynecol"},{"key":"R35-6-20210128","doi-asserted-by":"crossref","first-page":"584S","DOI":"10.1093\/ajcn\/85.2.584S","article-title":"Low birth weight in the United States.","volume":"85","author":"Goldenberg","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"R36-6-20210128","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3109\/00048670903559593","article-title":". Neonatal growth outcomes at birth and one month postpartum following in utero exposure to antidepressant medication.","volume":"44","author":"Lewis","year":"2010","journal-title":"Aust N Z J Psychiatry"},{"key":"R37-6-20210128","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1056\/NEJM199701233360404","article-title":". Neurodevelopment of children exposed in utero to antidepressant drugs.","volume":"336","author":"Nulman","year":"1997","journal-title":"N Engl J Med"},{"key":"R38-6-20210128","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1176\/appi.ajp.159.11.1889","article-title":". Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective, controlled study.","volume":"159","author":"Nulman","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R39-6-20210128","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1542\/peds.113.2.368","article-title":"Maternal selective serotonin reuptake inhibitor use during pregnancy and newborn neurobehavior.","volume":"113","author":"Zeskind","year":"2004","journal-title":"Pediatrics"},{"key":"R40-6-20210128","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/jama.279.8.609","article-title":". Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.","volume":"279","author":"Kulin","year":"1998","journal-title":"JAMA"},{"key":"R41-6-20210128","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/01.AOG.0000187302.61812.53","article-title":"Risks associated with selective serotonin reuptake inhibitors in pregnancy.","volume":"106","author":"Malm","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R42-6-20210128","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/bdra.20773","article-title":". Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy.","volume":"91","author":"Colvin","year":"2011","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R43-6-20210128","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1067\/mob.2003.172","article-title":". Birth outcomes after prenatal exposure to antidepressant medication.","volume":"188","author":"Hendrick","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R44-6-20210128","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0006-3223(00)00877-5","article-title":". Birth outcomes following prenatal exposure to fluoxetine.","volume":"48","author":"Cohen","year":"2000","journal-title":"Biol Psychiatry"},{"key":"R45-6-20210128","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","article-title":". Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants.","volume":"160","author":"Levinson-Castiel","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"R46-6-20210128","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/00048670903107583","article-title":". Serotonin discontinuation syndrome following in utero exposure to antidepressant medication: prospective controlled study.","volume":"43","author":"Galbally","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"key":"R47-6-20210128","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","article-title":". Neonatal signs after late in utero exposure to serotonin reuptake inhibitors literature review and implications for clinical applications.","volume":"293","author":"Moses-Kolko","year":"2005","journal-title":"JAMA"},{"key":"R48-6-20210128","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0140-6736(05)17865-9","article-title":". Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis.","volume":"365","author":"Sanz","year":"2005","journal-title":"Lancet"},{"key":"R49-6-20210128","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","article-title":". Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations.","volume":"60","author":"Laine","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"R50-6-20210128","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/j.2055-2335.2010.tb00557.x","article-title":"Hospital pharmacy dispensing records for pharmacoepidemiology research into late gestation exposure to antidepressants.","volume":"40","author":"Grzeskowiak","year":"2010","journal-title":"J Pharm Pract Res"},{"key":"R53-6-20210128","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2431-5-13","article-title":". Optimal fetal growth for the Caucasian singleton and assessment of appropriateness of fetal growth: an analysis of a total population perinatal database online.","volume":"5","author":"Blair","year":"2005","journal-title":"BMC Pediatr"},{"key":"R55-6-20210128","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2125.2007.03048.x","article-title":". Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.","volume":"65","author":"Bakker","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"R56-6-20210128","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1177\/0091270010373928","article-title":". Patterns of antidepressant medication use among pregnant women in a United States population.","volume":"51","author":"Alwan","year":"2011","journal-title":"J Clin Pharmacol"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JCP.0b013e31826686bc","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,28]],"date-time":"2024-04-28T18:24:44Z","timestamp":1714328684000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004714-201210000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":53,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31826686bc","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}